Life Sciences

  • Share

Life Sciences assurance services

You can count on us to provide different types of assurance services to help validate critical information being communicated to an entity’s stakeholders.

Additionally, our assurance professionals leverage the skills and knowledge of our entire life sciences practice to bring a clear perspective and relevant insight to management, audit committees and other key stakeholders.

We can provide attestation services as required by global or local regulations including:

  • Financial statement attestation (including compliance with SEC reporting requirements and IFRS)
  • Fraud, investigation and dispute services, including contract dispute and royalty reviews
  • Internal control compliance attestation
  • Assistance with mergers and acquisitions, including buy-side and sell-side due diligence
  • Financial accounting advisory services
  • Performance of agreed upon procedures and related reporting
  • Climate change and sustainability reporting
  • IPO readiness assessments
  • Government contract and grant compliance attestation

Related content

EY - Accounting for financing arrangements in the life sciences sector: US GAAP accounting considerations for option-based deals

Accounting for financing arrangements in the life sciences sector: US GAAP accounting considerations for option-based deals

Financing is fundamental to life sciences companies and accounting considerations may affect how transactions are structured. We discuss an option-based structure under US GAAP.


EY - Accounting for financing arrangements in the life sciences sector: IFRS accounting considerations for option-based deals

Accounting for financing arrangements in the life sciences sector: IFRS accounting considerations for option-based deals

Financing is fundamental to life sciences companies and accounting considerations may affect how transactions are structured. We discuss an option-based structure under IFRS.


EY - Technical line: How changed to the definition of a business willl effect life sciences entities

Technical line: How changed to the definition of a business willl effect life sciences entities

New FASB guidance on the definition of a business will likely result in more acquisitions being accounted for as asset acquisitions rather than business combinations.

 

Connect with us

Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.